Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen G Ellis

Showing results (151-160 of 252) with videos related to

Pageof 26
Sort By:
JACC. Cardiovascular Interventions|December 27, 2016
Efficacy and Safety of the Absorb Everolimus-Eluting Bioresorbable Scaffold for Treatment of Patients With Diabetes Mellitus: Results of the Absorb Diabetic SubstudyDean J Kereiakes, Stephen G Ellis, Takeshi Kimura, et al.
The American Journal of Cardiology|February 7, 2009
An integrated TAXUS IV, V, and VI intravascular ultrasound analysis of the predictors of edge restenosis after bare metal or paclitaxel-eluting stentsJian Liu, Akiko Maehara, Gary S Mintz, et al.
The American Journal of Cardiology|October 29, 2005
Impact of coronary culprit lesion calcium in patients undergoing paclitaxel-eluting stent implantation (a TAXUS-IV sub study)Issam Moussa, Stephen G Ellis, Michael Jones, et al.
JAMA|March 15, 2006
Paclitaxel-eluting stents vs vascular brachytherapy for in-stent restenosis within bare-metal stents: the TAXUS V ISR randomized trialGregg W Stone, Stephen G Ellis, Charles D O'Shaughnessy, et al.
The New England Journal of Medicine|January 16, 2004
A polymer-based, paclitaxel-eluting stent in patients with coronary artery diseaseGregg W Stone, Stephen G Ellis, David A Cox, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|December 15, 2012
Long term follow-up of drug eluting versus bare metal stents in the treatment of saphenous vein graft lesionsLuiz F Ybarra, Henrique B Ribeiro, Antonio H Pozetti, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|June 9, 2021
Optimal dual antiplatelet therapy duration for bioresorbable scaffolds: an individual patient data pooled analysis of the ABSORB trialsLorenzo Azzalini, Stephen G Ellis, Dean J Kereiakes, et al.
Circulation|April 14, 2004
One-year clinical results with the slow-release, polymer-based, paclitaxel-eluting TAXUS stent: the TAXUS-IV trialGregg W Stone, Stephen G Ellis, David A Cox, et al.
American Heart Journal|September 21, 2015
Evaluation of a fully bioresorbable vascular scaffold in patients with coronary artery disease: design of and rationale for the ABSORB III randomized trialDean J Kereiakes, Stephen G Ellis, Jeffrey J Popma, et al.
JACC. Cardiovascular Interventions|September 23, 2017
Efficacy and Safety of the Absorb Bioresorbable Vascular Scaffold in Females and Males: Results of an Individual Patient-Level Pooled Meta-Analysis of Randomized Controlled TrialsSatya Shreenivas, Dean J Kereiakes, Stephen G Ellis, et al.
Pageof 26

Showing results (151-160 of 252) with videos related to

Sort By:
Pageof 26
JACC. Cardiovascular Interventions|December 27, 2016
Efficacy and Safety of the Absorb Everolimus-Eluting Bioresorbable Scaffold for Treatment of Patients With Diabetes Mellitus: Results of the Absorb Diabetic SubstudyDean J Kereiakes, Stephen G Ellis, Takeshi Kimura, et al.
The American Journal of Cardiology|February 7, 2009
An integrated TAXUS IV, V, and VI intravascular ultrasound analysis of the predictors of edge restenosis after bare metal or paclitaxel-eluting stentsJian Liu, Akiko Maehara, Gary S Mintz, et al.
The American Journal of Cardiology|October 29, 2005
Impact of coronary culprit lesion calcium in patients undergoing paclitaxel-eluting stent implantation (a TAXUS-IV sub study)Issam Moussa, Stephen G Ellis, Michael Jones, et al.
JAMA|March 15, 2006
Paclitaxel-eluting stents vs vascular brachytherapy for in-stent restenosis within bare-metal stents: the TAXUS V ISR randomized trialGregg W Stone, Stephen G Ellis, Charles D O'Shaughnessy, et al.
The New England Journal of Medicine|January 16, 2004
A polymer-based, paclitaxel-eluting stent in patients with coronary artery diseaseGregg W Stone, Stephen G Ellis, David A Cox, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|December 15, 2012
Long term follow-up of drug eluting versus bare metal stents in the treatment of saphenous vein graft lesionsLuiz F Ybarra, Henrique B Ribeiro, Antonio H Pozetti, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|June 9, 2021
Optimal dual antiplatelet therapy duration for bioresorbable scaffolds: an individual patient data pooled analysis of the ABSORB trialsLorenzo Azzalini, Stephen G Ellis, Dean J Kereiakes, et al.
Circulation|April 14, 2004
One-year clinical results with the slow-release, polymer-based, paclitaxel-eluting TAXUS stent: the TAXUS-IV trialGregg W Stone, Stephen G Ellis, David A Cox, et al.
American Heart Journal|September 21, 2015
Evaluation of a fully bioresorbable vascular scaffold in patients with coronary artery disease: design of and rationale for the ABSORB III randomized trialDean J Kereiakes, Stephen G Ellis, Jeffrey J Popma, et al.
JACC. Cardiovascular Interventions|September 23, 2017
Efficacy and Safety of the Absorb Bioresorbable Vascular Scaffold in Females and Males: Results of an Individual Patient-Level Pooled Meta-Analysis of Randomized Controlled TrialsSatya Shreenivas, Dean J Kereiakes, Stephen G Ellis, et al.
Pageof 26